Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcuma longa oral gel for radiation-induced oral mucositis
NCT05982197Completed
- Sponsor
- University of Baghdad
- Start
- Jan 2023
- Primary completion
- Mar 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised trial of curcumin in oral mucositis (OM) (2 arms), sponsored by University of Baghdad. Primary endpoints: Onset of radiation induced mucositis up to 2 months and Change in severity of radiation induced mucositis up to 2 months. Started Jan 2023; status: completed.
02
Drugs
curcumin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05982197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05982197.